VRCA
Verrica Pharmaceuticals Inc.
Nasdaq: VRCA · West Chester, PA · Healthcare
$5.02-0.42 (-7.72%)Closed
Market Cap$86.2M
Cash$20.6Mmost recent
Runway7 mo$9.2M Q burn
P/E (TTM)—EPS $-1.68
52-Wk Range$3.28 – $9.10
Avg Volume173.0K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$5.02-93.1%
Pipeline
Drug candidates sponsored by VRCA · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for VRCA. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.